Showing results (561-570 of 884) with videos related to

Sort By:
Pageof 89
Stem Cell Reviews and Reports|May 12, 2026
iPSC-Derived 3D Brain Organoids as Next-generation Platforms to Study Viral and Toxicant-associated NeurodegenerationMd Shahadab, Vaishali Saini, Siddharth Singh, et al.
Abdominal Imaging|April 25, 2014
Clinical characteristics and imaging features of small bowel adenocarcinomas in Crohn's diseaseNicholas K Weber, Joel G Fletcher, Jeff L Fidler, et al.
The New England Journal of Medicine|September 26, 2019
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative ColitisBruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, et al.
Inflammatory Bowel Diseases|December 16, 2020
Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel DiseasesSiddharth Singh, Herbert C Heien, Lindsey Sangaralingham, et al.
Protein Expression and Purification|December 13, 2017
Expression of fibronectin-binding protein of L. acidophilus NCFM and in vitro refolding to adhesion capable native-like protein from inclusion bodiesSonu Bisht, Kumar Siddharth Singh, Ritu Choudhary, et al.
American Journal of Clinical Oncology|May 25, 2017
Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer-related Mortality: A Systematic Review and Meta-AnalysisArjun Gupta, Avash Das, Kaustav Majumder, et al.
The Lancet. Gastroenterology & Hepatology|August 21, 2018
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analysesNghia H Nguyen, Mathurin Fumery, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|December 2, 2021
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatmentWilliam J Sandborn, Nervin Lawendy, Silvio Danese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2008
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's diseaseJennifer Jones, Edward V Loftus, Remo Panaccione, et al.
Gastroenterology|October 14, 2008
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM studyBrian G Feagan, Remo Panaccione, William J Sandborn, et al.
Pageof 89